| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $74.9M | +36.3% |
| Cost of Revenue | $31.5M | +52.0% |
| Gross Profit | $43.4M | +26.8% |
| R&D Expense | $23.2M | +47.8% |
| SG&A Expense | $79.7M | +56.1% |
| Operating Income | -$66.1M | -68.2% |
| Pre-tax Income | -$70.5M | -63.7% |
| Income Tax | $123K | +187.9% |
| Net Income | -$70.6M | -64.5% |
| EPS (Basic) | -$1.87 | -13.3% |
| EPS (Diluted) | -$1.87 | -12.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.2M | -34.4% |
| Short-term Investments | $7.0M | — |
| Accounts Receivable | $9.7M | +3.0% |
| Inventory | $14.5M | +60.7% |
| Current Assets | $112.2M | -20.3% |
| Total Assets | $176.0M | -7.8% |
| Current Liabilities | $37.1M | +33.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.5M | -48.3% |
| Capital Expenditures | $7.4M | +44.5% |
| Investing Cash Flow | -$14.1M | -176.4% |
| Financing Cash Flow | $28.7M | -79.0% |
| Free Cash Flow | -$60.9M | -47.8% |
| Long-term Debt |
| $63.3M |
| +94.9% |
| Total Liabilities | $117.5M | +68.9% |
| Stockholders' Equity | $58.6M | -51.7% |